Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
Audrey Simonaggio, Réza Elaidi, Laure Fournier, Elizabeth Fabre, Victoria Ferrari, Delphine Borchiellini, Jonathan Thouvenin, Philippe Barthélémy, Constance Thibault, Éric Tartour, Stéphane Oudard, Yann Vano
Topics & Concepts
MedicineNivolumabInternal medicineRenal cell carcinomaProportional hazards modelLung cancerNeutrophil to lymphocyte ratioProgression-free survivalOncologyCohortRetrospective cohort studyMultivariate analysisCancerGastroenterologyLymphocyteImmunotherapyOverall survivalInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersLung Cancer Research Studies